All News

Electronic symptom self-measuring provided early detection of toxic effects and helped anticipate necessary medical interventions for pediatric patients with cancer.

Driving distance is not a predictor of accessibility for those who do not have a car or access to public transportation, investigators say.

If approved the drug will be the first allogeneic advanced stem cell therapy donor source for patients with blood cancers.

The suggested wave 4 of the opioid crisis saw high opioid-involved overdose death rates in urban counties and high acceleration of overdose deaths in rural counties, indicating that the opioid crisis worsened during the COVID-19 pandemic.

Delays in anticancer drug therapy, radiation, and surgery were found to be associated with factors such as race and ethnicity, multimorbidity, COVID-19 vaccination, and severity of COVID-19, suggesting disparities in cancer care.

Pharmacists need to focus on taking care of themselves while they continue to take care of others in even bigger ways post-COVID-19 pandemic.

Brinzolamide/brimonidine tartrate (Simbrinza) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

SilverSeal provides topical management of minor superficial wounds, lacerations, and abrasions, as well as minor first-degree burns.

As leaders, we should ask ourselves if any of our people might feel imposter syndrome and what can we do to calm their anxiety and boost their confidence.

Effective pharmacy managers help everyone to see the proverbial forest through the trees.

Participants who initiated treatment with Biktarvy demonstrated superior hepatitis B virus (HBV) DNA suppression and HBV e-antigen seroconversion.

Increasing population immunity decreased transmission of COVID-19 and allowed for reductions in quarantine and testing, encouraging 2-dose vaccine and booster uptake.

Case management programs or pharmacist-delivered high-touch care are critical components in medical specialty drug management.

The next-generation vaccine candidate, BNT162b5, consists of RNAs encoding enhanced prefusion spike proteins for the SARS-CoV-2 ancestral strain and an Omicron variant.

IMscin001 analysis shows non-inferior levels of the cancer immunotherapy in the blood compared with intravenous infusion in individuals with advanced non–small cell lung cancer.

Findings in a new trial show that dietary supplementation of resistant starch has the potential to decrease people’s risk of certain types of gastrointestinal cancers.

Ranibizumab-eqrn is the only biosimilar approved for all 5 Lucentis indications.

Gamma-delta T-cells undergo a biochemical change that leads them to spur the growth of tumors that previously restricted.

Ezetimibe (Zetia) is an inhibitor of intestinal cholesterol and related phytosterol absorption indicated as an adjunct to diet to reduce elevated total cholesterol.

Dermala helps support hormonal balance, which may help in the treatment of acne.

Using computational methods, the development of an HIV therapy cocktail based on the virus’ genetics was found to increase the efficacy of treatment.

A new case study found that depictions of diverse female scientists on social media inspired other women in STEM, but stereotypes of how women in STEM should look and dress persist in comments section.

Pharmacists have the potential to help optimize treatment and maximize supportive care management for targeted therapies.

Health care facilities in counties with higher Black populations and in rural areas were less likely to serve as COVID-19 vaccination facilities during May 2021, indicating disparities in vaccine distribution.

Increasingly, practices will use and evaluate ePROs and DSMSTs in cancer care settings.

Submissions are based on 3 phase 3 clinical trials showing that the drug achieved the co-primary endpoints of clinical remission and endoscopic response as induction and maintenance treatment.

Pharmacists have a key role in monitoring patients on statin therapy and identifying statin intolerance.

Abbott will work with the FDA to expedite the review of their deep brain stimulation system to treat the life-threatening disease of treatment-resistant depression.